Pharmaron Beijing Co Ltd Ordinary Shares - Class H 03759
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 10.96
- Day Range
- HKD 11.04–11.64
- 52-Week Range
- HKD 8.25–23.40
- Bid/Ask
- HKD 11.14 / HKD 11.16
- Market Cap
- HKD 19.91 Bil
- Volume/Avg
- 11.8 Mil / 5.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 11.26
- Price/Sales
- 1.57
- Dividend Yield (Trailing)
- 2.95%
- Dividend Yield (Forward)
- 2.10%
- Total Yield
- 2.95%
Company Profile
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Growth
- Total Number of Employees
- 20,295
- Website
- https://www.pharmaron.com
Comparables
Valuation
|
Metric
|
03759
|
688253
|
000710
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.26 | 23.76 | — |
Price/Book Value | 1.43 | 2.84 | 1.67 |
Price/Sales | 1.57 | 9.05 | 2.85 |
Price/Cash Flow | 6.09 | 13.72 | 29.82 |
Price/Earnings
03759
688253
000710
Financial Strength
|
Metric
|
03759
|
688253
|
000710
|
|---|---|---|---|
Quick Ratio | — | 10.60 | 1.63 |
Current Ratio | — | 11.04 | 2.02 |
Interest Coverage | — | 1,693.02 | — |
Quick Ratio
03759
688253
000710
Profitability
|
Metric
|
03759
|
688253
|
000710
|
|---|---|---|---|
Return on Assets (Normalized) | 5.76% | 4.47% | −13.01% |
Return on Equity (Normalized) | 11.35% | 4.81% | −18.59% |
Return on Invested Capital (Normalized) | 7.64% | 4.51% | −15.87% |
Return on Assets
03759
688253
000710
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vzkywmgmkk | Vylnc | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Trdhxdpj | Vksqyv | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Myfrbvymm | Wmdvb | $107.6 Bil | |
MRNA
| Moderna Inc | Gdcmbbhyy | Pxbxn | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Wtlfpgfd | Cngd | $22.2 Bil | |
ARGX
| argenx SE ADR | Fvjszxljf | Fmr | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ycxvgym | Nkkbdfw | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Gbhpysf | Nbfnw | $15.1 Bil | |
INCY
| Incyte Corp | Gvpkzcs | Tjzvdtw | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Yprdcypb | Cbddx | $12.7 Bil |